FirmaIQ
Org.nr 991 036 393 AS · OSLO · 72.100 Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk Ullernchausséen 64, 0379 OSLO Latest filing: Årsregnskap 2025 · approved 30.06.2026 · journal 2026 623409 Analysis generated: 09 Sep 2026 · Auto-onboard

PCI BIOTECH HOLDING ASA

PCI BIOTECH HOLDING ASA · 19 published annual accounts (2006–2025). Latest year revenue 2.9m NOK, net result -42.3m NOK, equity 2.9m NOK, cash 154.0k NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall.

Auto summary · grounded in R2006–R2025
Reported fact Calculated Interpretation Unknown

Smart Search OSINT dossier

Simple version

Explain it like I’m ten

Numbers from the 2025 accounts. [R2025]

How much they sold
About 2.9m

Operating income / revenue in 2025.

Did they make money?
-42.3m

Net result for 2025.

What’s left in the company
Equity 2.9m

Book equity at year-end.

Cash
154.0k

Bank deposits and cash (when disclosed).

At a glance · 2025

Key figures

Revenue / sales
2 945 000
NOK · [R2025]
Net result
-42 290 000
NOK · [R2025]
Equity
2 900 000
NOK · [R2025]
Cash
154 000
NOK · [R2025]
Total assets
8 607 000
NOK · [R2025]
Paid-in equity
2 900 000
NOK · [R2025]

Trends

19-year arc

Charts use figures extracted from published annual reports.

Sales / revenue

Equity & cash

Cost / investment lines

Salary costs (lønnskostnader)

FTEs (årsverk)

From notes when disclosed; blank years mean not found in OCR.